Saitama, Japan

Kenji Osawa

USPTO Granted Patents = 5 


Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kenji Osawa: Innovator in Antibody Development

Introduction

Kenji Osawa is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of five patents to his name, Osawa's work focuses on innovative solutions for treating various medical conditions.

Latest Patents

One of Kenji Osawa's latest patents is the Anti-ALK2 antibody. This application provides an antibody that specifically binds to an ALK2 protein and has the activity of inhibiting BMP signal transduction mediated by ALK2. It also includes a method for producing the antibody and a pharmaceutical composition comprising the antibody, aimed at treating and/or preventing ectopic ossification, bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).

Career Highlights

Throughout his career, Kenji Osawa has worked with notable institutions, including Saitama Medical University and Daiichi Sankyo Company, Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical therapies.

Collaborations

Kenji Osawa has collaborated with esteemed colleagues such as Takenobu Katagiri and Sho Tsukamoto. These partnerships have further enriched his research and expanded the impact of his inventions.

Conclusion

Kenji Osawa's work in antibody development showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his significant role in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…